ADNECTIN



Trademark Coverage

No Class Specified

Biotechnology and pharmaceutical products, namely, therapeutic proteins for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Timeline
  • Mar 12
    2013
    TEAS Change Of Correspondence Received
  • Mar 11
    2013
    Abandonment Notice Mailed No Use Statement Filed
  • Mar 11
    2013
    Abandonment No Use Statement Filed
  • Jul 25
    2012
    Notice Of Approval Of Extension Request Mailed
  • Jul 23
    2012
    Extension 1 Granted
  • Jul 23
    2012
    Extension 1 Filed
  • Jul 23
    2012
    TEAS Extension Received
  • Feb 07
    2012
    NOA Mailed SOU Required From Applicant
  • Dec 13
    2011
    Published For Opposition
  • Nov 23
    2011
    Notice Of Publication
  • Nov 04
    2011
    Law Office Publication Review Completed
  • Nov 04
    2011
    Assigned To LIE
  • Oct 11
    2011
    Approved For PUB Principal Register
  • Sep 13
    2011
    Non Final Action Mailed
  • Sep 12
    2011
    Non Final Action Written
  • Sep 09
    2011
    Assigned To Examiner
  • May 26
    2011
    New Application Office Supplied Data Entered In TRAM
  • May 26
    2011
    New Application Entered In TRAM